Evidence map›Paper›PMID 27449105›Full record

ArticleOncotarget2016

miR-29 regulates Tet1 expression and contributes to early differentiation of mouse ESCs.

Yanhua Cui, Ting Li, Dehua Yang, Song Li, Weidong Le

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. A Systematic Review of miR-29 in Cancer.Molecular therapy oncolytics · 2019
    Review
  12. Article
  13. Article
  14. Tet Enzymes, Variants, and Differential Effects on Function.Frontiers in cell and developmental biology · 2018
    Review
  15. Article
  16. Article
  17. Review
  18. MicroRNA-29: A Crucial Player in Fibrotic Disease.Molecular diagnosis & therapy · 2017
    Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 1 country.

Yanhua CuiCenter for Translational Research on Neurological Diseases, the First Affiliated Hospital, Dalian Medical University, Dalian, China.
Ting LiKey Laboratory of Stem Cell Biology, Institute of Health Sciences, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai, China.
Dehua YangKey Laboratory of Stem Cell Biology, Institute of Health Sciences, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai, China.
Song LiCenter for Translational Research on Neurological Diseases, the First Affiliated Hospital, Dalian Medical University, Dalian, China.
Weidong LeCenter for Translational Research on Neurological Diseases, the First Affiliated Hospital, Dalian Medical University, Dalian, China.
Dalian Medical University · CNChinese Academy of Sciences · CNFirst Affiliated Hospital of Dalian Medical University · CNShanghai Institutes for Biological Sciences · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The ten-eleven translocation-1 (Tet1), which converts 5-methylcytosine (5mC) to 5-hydroxymethycytosine (5hmC), plays important roles in many important biological processes, such as mouse embryonic stem cells (ESCs) maintenance. However, the mechanisms for Tet-1 regulation remain largely unknown. Here we showed that miR-29 family (miR-29a, miR-29b and miR-29c) can directly repress Tet1 expression. We found that Tet1 was highly expressed and 5hmC was presented at relatively high levels in mouse ESCs, but the levels of both Tet1 and 5hmC were reduced during the early differentiation of ESCs. On the contrary, miR-29 level was increased in this process. ESCs stably transfecting with miR-29 precursors showed lower levels of Tet1 protein and 5hmC. Furthermore, we demonstrated that miR-29 overexpression selectively affected cell lineage markers and skewed ESC differentiation, which was similar in Tet1 knockdown ESCs. Our results indicate that miR-29 is a direct regulator of Tet1 in mouse ESCs.

Indexed as

5-MethylcytosineAnimalsAntigens, DifferentiationCell DifferentiationCell LineCell LineageDNA-Binding ProteinsDNA MethylationEmbryonic Stem CellsGene Expression Regulation, DevelopmentalHumansMiceMicroRNAsProto-Oncogene ProteinsRNA, Small InterferingTranslocation, Genetic5-MethylcytosineAntigens, DifferentiationDNA-Binding ProteinsMicroRNAsMIRN29 microRNA, mouseProto-Oncogene ProteinsRNA, Small InterferingTET1 protein, mouse5hmCembryonic stem cellsmiR-29 familyTet1

Identifiers

PMID27449105
PMCPMC5323127
OpenAlexW2483198245

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.